Statistics
Publications
101
Citations
6.9K
H-Index
36
Active since
2007
Anthony R. Mato is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, chronic lymphocytic leukemia therapy, and oncology.
Publications per year
2007–2024
101
101
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
Tait D. Shanafelt, Xin V. Wang, Neil E. Kay et al. · New England Journal of Medicine · 2019 · 738 citations · Full text
Medicine, Immunology, Oncology +16
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
Anthony R. Mato, Nirav N. Shah, Wojciech Jurczak et al. · The Lancet · 2021 · 454 citations · Full text
Medicine, Oncology, Pharmacology +12
Outcomes of COVID-19 in patients with CLL: a multicenter international experience
Anthony R. Mato, Lindsey E. Roeker, Nicole Lamanna et al. · Blood · 2020 · 318 citations · Full text
1–5 of 101